Company profile
Neupulse - Improving the lives of people with Tourettes
An important focus of our research into Tourette syndrome over the last few years has been to understand how the brain networks that give rise to tics could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MjM2NTQwN2FkaXF6a2N4
Published 07 Nov 2024 11:47
Company registered at Companies House
Neurotherapeutics Ltd is a University of Nottingham spin-out MedTech company that is aimed at developing medical devices for the reduction of tics and suppression of the urge-to-tic in Tourette syndrome
Neurotherapeutics Ltd recently won the 'One to Watch' category in the 2022 Meditech Midlands Business Awards and was shortlisted in two additional categories.
https://www.nottingham.ac.uk/news/spin-out-company-launched-deliver-wrist-device-control-tourettes
